Authors:
PAPPOT H
PFEIFFER P
GRONDAHLHANSEN J
SKOV BG
Citation: H. Pappot et al., PRESENCE OF UROKINASE PLASMINOGEN-ACTIVATOR, ITS INHIBITOR AND RECEPTOR IN SMALL-CELL LUNG-CANCER AND NONSMALL CELL LUNG-CANCER, International journal of oncology, 10(1), 1997, pp. 177-182
Authors:
SKOV BG
BROHOLM H
ENGEL U
FRANZMANN MB
NIELSEN AL
LAURITZEN AF
SKOV T
Citation: Bg. Skov et al., COMPARISON OF THE REPRODUCIBILITY OF THE WHO CLASSIFICATIONS OF 1975 AND 1994 OF ENDOMETRIAL HYPERPLASIA, International journal of gynecological pathology, 16(1), 1997, pp. 33-37
Citation: H. Pappot et al., LEVELS OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 AND UROKINASE PLASMINOGEN-ACTIVATOR RECEPTOR IN NONSMALL CELL LUNG-CANCER AS MEASURED BY QUANTITATIVE ELISA AND SEMIQUANTITATIVE IMMUNOHISTOCHEMISTRY, Lung cancer, 17(2-3), 1997, pp. 197-209
Authors:
SKOV BG
LAURITZEN AF
HIRSCH FR
SKOV T
NIELSEN HW
Citation: Bg. Skov et al., DIFFERENTIATION OF ADENOCARCINOMA OF THE LUNG AND MALIGNANT MESOTHELIOMA - PREDICTIVE VALUE AND REPRODUCIBILITY OF IMMUNOREACTIVE ANTIBODIES, Histopathology, 25(5), 1994, pp. 431-437
Citation: Bg. Skov et al., THE HISTOPATHOLOGICAL DIAGNOSIS OF MALIGNANT MESOTHELIOMA V PULMONARYADENOCARCINOMA - REPRODUCIBILITY OF THE HISTOPATHOLOGICAL DIAGNOSIS, Histopathology, 24(6), 1994, pp. 553-557
Authors:
SKOV BG
BRAENDSTRUP O
HIRSCH FR
LAURITZEN AF
NIELSEN HW
SKOV T
Citation: Bg. Skov et al., ARE PATHOLOGISTS BIASED BY CLINICAL INFORMATION - A BLINDED CROSS-OVER STUDY OF THE HISTOPATHOLOGICAL DIAGNOSIS OF MESOTHELIAL TUMORS VERSUS PULMONARY ADENOCARCINOMA, Lung cancer, 11(5-6), 1994, pp. 365-372
Citation: Bg. Skov et al., ME1-ANTIBODY LABELING OF PRIMARY BRONCHOGENIC TUMORS AND EXTRAPULMONARY MALIGNANCIES, Lung cancer, 11(3-4), 1994, pp. 221-227